Not Yet RecruitingNot Applicable

Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole

175 participantsStarted 2026-01-10

Plain-language summary

This Prospective study will be conducted To copare uterine blood flow using Doppler ultrasound before and after evacuation of hydatiform mole between female patients with remissions and those with development of post-molar persistent gestational trophoblastic neoplasia to detect accuracy,efficacy,predictive value and acceptability of uterine artery doppler in predicting gestional trophoblastic neoplasia .

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with confirmed diagnosis of complete hydatiform mole. * Hemodynamically stable patient . * No contraindication for anesthetic materials used for the evacuation . * Acceptance of possible prolonged follow up , repeated uterine artery doppler ultrasound ,repeated HCG tests Exclusion Criteria: * Patient refusal to participate in the study. * Patient with incomplete hydatiform mole . * Patients who were lost during the follow-up period after this procedure. * Contraindication for anesthetic materials used for the evacuation .

What they're measuring

Uterine artery Doppler flow velocimetry

Timeframe: We will perform DFV of uterine arteries on both sides at admission and 4 - 6 weeks after evacuation.

Trial details

NCT IDNCT07333326

SponsorMinia University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-01-10

Contact for this trial

Mohamed Tawfiek Gad el Rab, Professor

+201061174636 mohammedtawfiek@gmail.com

View on ClinicalTrials.gov More Gestational Trophoblastic Neoplasia trials